Introduction
The human right to the highest achievable standard of health obliges countries to ensure universal and timely access to high-quality healthcare and to address the underlying factors contributing to health disparities [1]. Yet, access remains uneven: people with low incomes, insecure residence status or communication difficulties often face restricted access to healthcare, disadvantages that disproportionately affect and accumulate in migrant populations [2, 3]. Ensuring inclusive access is therefore not only a matter of equity but also essential for effective public health. In order to combat inequitable access to healthcare, decision-makers and other stakeholders in the field of migration and health need high-quality evidence on what works effectively and sustainably to overcome barriers, at what cost and in what context [4]. While many high-income health systems explicitly take into account health economic criteria when making reimbursement decisions, this evidence base remains comparatively limited when it comes to migration health policies [5].
In health policy debates, economic arguments are frequently invoked to frame migration as a cost pressure on public health systems and to justify cost-containment measures. For example, subsidies for translation services have been cut or user fees introduced, often on the grounds of short-term public savings [6, 7]. Such decisions typically focus on direct expenditures while overlooking potential adverse health and broader long-term consequences of inadequate communication, including increased costs associated with delayed care, medical errors, avoidable complications and additional healthcare use [8]. From both a health systems and human rights perspective, addressing language barriers is integral to quality and equitable care; neglecting them can lead to avoidable health harms and higher societal costs.
Economic arguments increasingly intersect with claims that universal health coverage is essential for global sustainable development [9]. This has shifted attention towards the costs of inaction, particularly the economic implications of excluding migrants and refugees from healthcare systems [10-13]. Yet despite growing policy relevance, robust evidence remains limited. The WHO Global Research Agenda identifies health financing for migrants and displaced populations as an understudied topic and highlights the need for studies on the cost-effectiveness of inclusion policies [14]. Thus, the economic case for equitable access to healthcare for migrants remains insufficiently developed.
This viewpoint examines how economic considerations are addressed in migration and health research and expert discourse, aims to raise awareness of critical evidence gaps and outlines the next steps required to develop robust, context-sensitive economic evidence for equitable migrant health policies.
Insights from scientific literature and experts
Rapid literature review
A rapid review examining how economic considerations were addressed in migration and health research between 2013 and 2023 identified 192 relevant studies, which were thematically analysed. Six principal themes emerged (see table S1 in the appendix). Most articles discussed costs as barriers to equitable healthcare access, primarily from migrants’ or providers’ perspectives. Fewer studies addressed policy discussions and analyses regarding migrant healthcare, economic evaluations and cost analyses, or cost-effectiveness assessments of health technologies, programmes and strategies. Only a few studies explored the effects of remittances or precarious financial conditions on migrant health. Across themes, economic aspects were largely treated descriptively with limited empirical grounding. Formal economic evaluations, particularly of the costs of exclusion or delayed access to care, were rare. Overall, the findings suggest that when economic arguments are raised in migration and health debates, they are seldom supported by systematic economic studies or evaluations. Further methodological details and thematic findings are provided in the appendix.
Expert consultations
To complement the review, we conducted two expert consultations: an online survey among members of the Migration Health and Development Research Initiative (MHADRI; described in the appendix) and a workshop held at the 2nd World Congress on Migration, Ethnicity, Race & Health. Across both consultations, economic perspectives were considered highly relevant to migration health debates.
The survey was presented and discussed in the Steering Committee of the Migration Health and Development Research Initiative (MHADRI) meeting for approval. The Steering Committee approved its conduct and did not see the necessity for additional ethical approval as the survey questionnaire does not ask for sensitive data.
A key concern was the cost of providing healthcare to migrants for health systems, societies and for migrants themselves, as well as the economic consequences of excluding vulnerable groups such as undocumented migrants and refugees from care. Participants stressed the importance of examining not only direct expenditures but also longer-term and societal costs, including those resulting from delayed access, inadequate communication or lack of professional interpretation. They also highlighted broader economic dimensions, including the effects of migration on host economies, labour market integration, the impact of remittances on families, and the role of economic structures and policies as social determinants of health. Key evidence gaps concerned the costs of inaction and opportunity costs. Experts called for improved data availability, interdisciplinary collaboration, cross-border dialogue between host and home countries and context-sensitive case studies to showcase good practice models and make economic evidence more tangible for policy dialogue and practice. Further details are provided in the appendix.
Discussion
Economic perspectives remain peripheral in migration and health research. The review and expert consultations are indicative that cost arguments are frequently invoked but rarely supported by robust data. Formal economic evaluations seem to be scarce, despite the fact that many studies collect data that could inform cost analyses. This suggests a missed opportunity, likely reflecting limited collaboration between economists and migration health researchers. Several factors may explain the persistent evidence gap. Disciplinary differences in language and terminology, methods and priorities can hinder collaboration. In addition, researchers may hesitate because of concerns about potential misuse of economic evidence in restrictive policy discourses, including fears that analyses might reveal high costs of care or be taken out of context to further marginalise migrant groups in increasingly hostile policy discourses [15]. Although economic arguments may appear detached from human rights principles, they can strengthen rather than undermine the case for equitable healthcare access by demonstrating both the costs of exclusion and the broader societal benefits of inclusion.
Structural and institutional factors further shape the limited economic evidence base and influence which economic questions are investigated. Health financing mechanisms may disincentivise investment in services for refugees and undocumented migrants particularly where benefits are perceived as uncertain or linked to populations seen as only temporarily present in the country. For example, economic evaluations were more common for interventions framed as benefiting host populations (e.g. communicable disease screening) than for services primarily benefiting migrant groups [16]. In addition, migrants and refugees often have a limited voice in priority-setting processes, while services for migrants are frequently funded by international agencies and NGOs rather than national governments, leading to differing decision-making criteria, responsibilities and incentives. These structural dynamics underscore the need for closer collaboration between health economists, public health professionals, anthropologists, community representatives and migration specialists, as well as for research that captures both the costs and broader societal benefits (including contributions to labour markets and social cohesion) of investing in the health of migrants, while also considering previously neglected benefits for the resident population of host countries in the short- and long-term. Promising directions for future research include distributional cost-effectiveness studies, vignette-based studies or quasi-experimental designs as well as linked administrative and routine data to inform these topics. Interdisciplinary collaboration ensures that research questions, methods, assumptions and outcomes are context-sensitive and equity-orientated. Emerging national examples demonstrate that meaningful economic analyses in migration and health are feasible using existing data [17], suggesting that progress can be made without large additional funding.
Some limitations must be kept in mind for this viewpoint. The rapid review, based on two databases and restricted to English-language sources, may not have captured all relevant studies, potentially affecting comprehensiveness and generalisability of the findings. The survey and workshop reflect perspectives from specific expert communities in migration and health and had relatively low response rates; they do not represent the full diversity of stakeholders in the field. An important next step is to engage a broader range of stakeholders, including decision-makers and health economists to advance more inclusive and policy-relevant economic analyses in the field of migration health.
Conclusions
This Viewpoint highlights the need for robust, interdisciplinary research on the economic dimensions of migration health. Priorities include assessing the short- and long-term costs of inclusion and exclusion, examining broader economic determinants of migration health and developing context-sensitive case studies. Strengthening interdisciplinary collaboration will be essential to build the evidence base needed for advancing equitable, sustainable and human rights–based healthcare systems that recognise economic considerations not as barriers, but as catalysts for inclusion.
Open science statement
The data presented in this study are available on request from the corresponding author.